CCL
64
-4
EQT
47
-4
AKAM
61
5
AMAT
50
-2
FOXA
59
-4
VMC
53
-6
RIG
35
-6
SNA
50
-3
EMC
54
-2
PPL
60
-2
ZTS
19
2
TMO
50
-4
STT
71
-3
MET
64
-2
JNJ
57
-3
DOW
38
-2
NKE
43
-5
XRAY
28
-3
PHM
55
-3
SE
43
3
CCL
64
-4
EQT
47
-4
AKAM
61
5
AMAT
50
-2
FOXA
59
-4
VMC
53
-6
RIG
35
-6
SNA
50
-3
EMC
54
-2
PPL
60
-2
ZTS
19
2
TMO
50
-4
STT
71
-3
MET
64
-2
JNJ
57
-3
DOW
38
-2
NKE
43
-5
XRAY
28
-3
PHM
55
-3
SE
43
3
Financhill
Back

Hikma Pharmaceuticals Plc Vs. Nektar Therapeutics Industry Stock Comparison

Sell
31

HKMPY
Hikma Pharmaceuticals Plc

Last Price:
$40.39
Seasonality Move:
2.89%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.38
Seasonality Move:
11.58%
Sell
31
Hikma Pharmaceuticals Plc (HKMPY) is a Sell

Is Hikma Pharmaceuticals Plc a Buy, Sell or Hold?

  • The current Hikma Pharmaceuticals Plc [HKMPY] share price is $40.57. The Score for HKMPY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • HKMPY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HKMPY Stock Price Chart

What is Hikma Pharmaceuticals Plc's stock price today?

  • The Hikma Pharmaceuticals Plc share price today is $40.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HKMPY is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

HKMPY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.89 Sell
Relative Strength Index (14 RSI): 39.81 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

HKMPY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.23 Sell
20-day SMA: 41.5 Sell
50-day SMA: 44.52 Sell
200-day SMA: 50.03 Sell
8-day EMA: 41.04 Sell
20-day EMA: 41.77 Sell
50-day EMA: 43.67 Sell
200-day EMA: 48.28 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Hikma Pharmaceuticals Plc Earnings Growth & HKMPY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Hikma Pharmaceuticals Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):